Inhibition of Pseudomonas aeruginosa biofilm formation on wound dressings

Wound Repair and Regeneration

Volumn 23, Issue 6, 2015, Pages 842-854

  Brandenburg, Kenneth S ^a,f   Calderon, Diego F ^a   Kierski, Patricia R ^a   Brown, Amanda L ^a   Shah, Nihar M ^b   Abbott, Nicholas L ^c   Schurr, Michael J ^d,g   Murphy, Christopher J ^b,e   McAnulty, Jonathan F ^a   Czuprynski, Charles J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Wisconsin Electric Machines and Power Electronics Consortium   (United States)

^d Memorial Mission Hospital   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Bluegrass Advanced Materials   (United States)

^g Mission Medical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET; LECTIN; POLYSACCHARIDE; TRYPTOPHAN; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BIOFILM; BIOLOGICAL DRESSING; BIOMASS; CELL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SKIN INJURY; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; BANDAGE; DISEASE MODEL; DRUG EFFECTS; MICROBIOLOGY; MOUSE; PATHOLOGY; PSEUDOMONAS INFECTION; SOFT TISSUE INJURY; WOUND INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BIOFILMS; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SOFT TISSUE INJURIES; TRYPTOPHAN; WOUND HEALING; WOUND INFECTION;

EID: 84948429529     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12365     Document Type: Article

References (50)

1. Akers KS, Mende K, Cheatle KA, Zera WC, Yu X, Beckius ML, et al., Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis. BMC Infect Dis 2014; 14: 190.
2. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al., Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
3. Flemming H-C, Wingender J., The biofilm matrix. Nat Rev Microbiol 2010; 8: 623-33.
4. Lõpez D, Vlamakis H, Kolter R., Biofilms. Cold Spring Harb Perspect Biol 2010; 2: a000398.
5. Ma L, Jackson KD, Landry RM, Parsek MR, Wozniak DJ., Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol 2006; 188: 8213-21.
6. Nithya C, Begum MF, Pandian SK., Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1. Appl Microbiol Biotechnol 2010; 88: 341-58.
7. Sambanthamoorthy K, Gokhale AA, Lao W, Parashar V, Neiditch MB, Semmelhack MF, et al., Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner. Antimicrob Agents Chemother 2011; 55: 4369-78.
8. Nusbaum AG, Gil J, Rippy MK, Warne B, Valdes J, Claro A, et al., Effective method to remove wound bacteria: comparison of various debridement modalities in an in vivo porcine model. J Surg Res 2012; 176: 701-7.
9. Kathju S, Nistico L, Hall-Stoodley L, Post JC, Ehrlich GD, Stoodley P., Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surg Infect 2009; 10: 457-61.
10. Konig L, Klopfleisch R, Kershaw O, Gruber AD., Prevalence of biofilms on surgical suture segments in wounds of dogs, cats, and horses. Vet Pathol 2014; 52: 295-7.
11. Masini BD, Stinner DJ, Waterman SM, Wenke JC., Bacterial adherence to suture materials. J Surg Educ 2011; 68: 101-4.
12. Edmiston CE Jr, Krepel CJ, Marks RM, Rossi PJ, Sanger J, Goldblatt M, et al., Microbiology of explanted suture segments from infected and noninfected surgical patients. J Clin Microbiol 2013; 51: 417-21.
13. Henry-Stanley MJ, Hess DJ, Barnes AM, Dunny GM, Wells CL., Bacterial contamination of surgical suture resembles a biofilm. Surg Infect 2010; 11: 433-9.
14. Lipp C, Kirker K, Agostinho A, James G, Stewart P., Testing wound dressings using an in vitro wound model. J Wound Care 2010; 19: 220-6.
15. Schierle CF, De la Garza M, Mustoe TA, Galiano RD., Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009; 17: 354-9.
16. Roche ED, Renick PJ, Tetens SP, Ramsay SJ, Daniels EQ, Carson DL., Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds. Wound Repair Regen 2012; 20: 537-43.
17. Seth AK, Geringer MR, Gurjala AN, Hong SJ, Galiano RD, Leung KP, et al., Treatment of Pseudomonas aeruginosa biofilm-infected wounds with clinical wound care strategies: a quantitative study using an in vivo rabbit ear model. Plast Reconstr Surg 2012; 129: 262e-74e.
18. Zhao G, Usui ML, Underwood RA, Singh PK, James GA, Stewart PS, et al., Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen 2012; 20: 342-52.
19. Agarwal A, Nelson TB, Kierski PR, Schurr MJ, Murphy CJ, Czuprynski CJ, et al., Polymeric multilayers that localize the release of chlorhexidine from biologic wound dressings. Biomaterials 2012; 33: 6783-92.
20. Agarwal A, Weis TL, Schurr MJ, Faith NG, Czuprynski CJ, McAnulty JF, et al., Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cells. Biomaterials 2010; 31: 680-90.
21. Said SS, Aloufy AK, El-Halfawy OM, Boraei NA, El-Khordagui LK., Antimicrobial PLGA ultrafine fibers: interaction with wound bacteria. Eur J Pharm Biopharm 2011; 79: 108-18.
22. Favre-Bonté S, Köhler T, Van Delden C., Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 2003; 52: 598-604.
23. Bala A, Kumar R, Harjai K., Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J Med Microbiol 2011; 60: 300-6.
24. Singh PK, Parsek MR, Greenberg EP, Welsh MJ., A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 552-5.
25. Mulcahy H, Lewenza S., Magnesium limitation is an environmental trigger of the pseudomonas aeruginosa biofilm lifestyle. PLoS One 2011; 6: e23307.
26. Sanchez CJ Jr, Prieto EM, Krueger CA, Zienkiewicz KJ, Romano DR, Ward CL, et al., Effects of local delivery of D-amino acids from biofilm-dispersive scaffolds on infection in contaminated rat segmental defects. Biomaterials 2013; 34: 7533-43.
27. Sanchez CJ Jr, Akers KS, Romano DR, Woodbury RL, Hardy SK, Murray CK, et al., D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of staphylococcus aureus and pseudomonas aeruginosa. Antimicrob Agents Chemother 2014; 58: 4353-61.
28. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R., D-amino acids trigger biofilm disassembly. Science (New York, NY) 2010; 328: 627-9.
29. Hochbaum AI, Kolodkin-Gal I, Foulston L, Kolter R, Aizenberg J, Losick R., Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J Bacteriol 2011; 193: 5616-22.
30. Leiman SA, May JM, Lebar MD, Kahne D, Kolter R, Losick R., D-amino acids indirectly inhibit biofilm formation in Bacillus subtilis by interfering with protein synthesis. J Bacteriol 2013; 195: 5391-5.
31. Shimazaki J, Furukawa S, Ogihara H, Morinaga Y., L-Tryptophan prevents Escherichia coli biofilm formation and triggers biofilm degradation. Biochem Biophys Res Commun 2012; 419: 715-8.
32. Brandenburg KS, Rodriguez KJ, McAnulty JF, Murphy CJ, Abbott NL, Schurr MJ, et al., Tryptophan inhibits biofilm formation by Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013; 57: 1921-5.
33. Shen DK, Filopon D, Chaker H, Boullanger S, Derouazi M, Polack B, et al., High-cell-density regulation of the Pseudomonas aeruginosa type III secretion system: implications for tryptophan catabolites. Microbiology 2008; 154: 2195-208.
34. Farrow JM 3rd, Pesci EC., Two distinct pathways supply anthranilate as a precursor of the Pseudomonas quinolone signal. J Bacteriol 2007; 189: 3425-33.
35. Palmer GC, Jorth PA, Whiteley M., The role of two Pseudomonas aeruginosa anthranilate synthases in tryptophan and quorum signal production. Microbiology 2013; 159: 959-69.
36. Rutherford ST, Bassler BL., Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2012; 2 (11): pii: a012427.
37. Ito H, Ando T, Ogiso H, Arioka Y, Saito K, Seishima M., Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing. Biomaterials 2015; 53: 221-8.
38. Bandeira LG, Bortolot BS, Cecatto MJ, Monte-Alto-Costa A, Romana-Souza B., Exogenous tryptophan promotes cutaneous wound healing of chronically stressed mice through inhibition of TNF-alpha and IDO activation. PLoS One 2015; 10: e0128439.
39. Barouti N, Mainetti C, Fontao L, Sorg O., L-Tryptophan as a novel potential pharmacological treatment for wound healing via aryl hydrocarbon receptor activation. Dermatology (Basel, Switzerland) 2015; 230: 332-9.
40. Greenwood JE, Clausen J, Kavanagh S., Experience with biobrane: uses and caveats for success. Eplasty 2009; 9: e25.
41. O'Toole GA, Kolter R., Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998; 28: 449-61.
42. Ma L, Lu H, Sprinkle A, Parsek MR, Wozniak DJ., Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol 2007; 189: 8353-6.
43. Bhatia N, Demmer TA, Spiegelman VS., Inhibition of beta-TrCP function potentiates UVB-induced apoptosis in hTERT-immortalized normal human keratinocytes. Photochem Photobiol 2008; 84: 376-81.
44. Guthrie KM, Agarwal A, Tackes DS, Johnson KW, Abbott NL, Murphy CJ, et al., Antibacterial efficacy of silver-impregnated polyelectrolyte multilayers immobilized on a biological dressing in a murine wound infection model. Ann Surg 2012; 256: 371-7.
45. Herron M, Agarwal A, Kierski PR, Calderon DF, Teixeira LB, Schurr MJ, et al., Reduction in wound bioburden using a silver-loaded dissolvable microfilm construct. Adv Healthc Mater 2014; 3: 916-28.
46. Sterling JP, Heimbach DM, Gibran NS., Management of the burn wound. In:, Souba WW, Fink MP, editors. ACS surgery: principles and practice, 6th ed. WebMD Professional, New York, 2007.
47. Kathju S, Nistico L, Tower I, Lasko LA, Stoodley P., Bacterial biofilms on implanted suture material are a cause of surgical site infection. Surg Infect 2014; 15: 592-600.
48. Calfee MW, Coleman JP, Pesci EC., Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2001; 98: 11633-7.
49. Dawson B, Favaloro EJ., High rate of deficiency in the amino acids tryptophan and histidine in people with wounds: implication for nutrient targeting in wound management-a pilot study. Adv Skin Wound Care 2009; 22: 79-82.
50. Ito M, Ogawa K, Takeuchi K, Nakada A, Heishi M, Suto H, et al., Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J Dermatol Sci 2004; 36: 157-64.